Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among brokerages […]
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The […]
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $5.87 and traded as low as $4.30. Cogent Biosciences shares last traded at $4.38, with a volume of 1,172,921 shares traded. Analysts Set New Price Targets […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.87 and traded as low as $4.30. Cogent Biosciences shares last traded at $4.38, with a volume of 1,172,921 shares. Wall Street Analyst Weigh In Several […]
Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at Wedbush in a research note issued on Tuesday, RTT News reports. A number of other brokerages also recently commented on COGT. HC Wainwright dropped their target price on shares of Cogent Biosciences from $27.00 to $13.00 and set a […]